Filed: Apr. 10, 2017
Latest Update: Apr. 10, 2017
Summary: ORDER GRANTING STIPULATION OF DISMISSAL JAMES V. SELNA , District Judge . Upon consideration of the parties' Stipulation of Dismissal, and for good cause having been shown, IT IS HEREBY ORDERED THAT: 1. All claims of infringement of U.S. Patent No. 5,720,894 ("the '894 patent") that Lawrence Livermore National Security, LLC ("LLNS") has asserted or could have asserted against Abbott Medical Optics Inc. ("AMO") are dismissed with prejudice. 2. All claims of infringement of the '894 patent
Summary: ORDER GRANTING STIPULATION OF DISMISSAL JAMES V. SELNA , District Judge . Upon consideration of the parties' Stipulation of Dismissal, and for good cause having been shown, IT IS HEREBY ORDERED THAT: 1. All claims of infringement of U.S. Patent No. 5,720,894 ("the '894 patent") that Lawrence Livermore National Security, LLC ("LLNS") has asserted or could have asserted against Abbott Medical Optics Inc. ("AMO") are dismissed with prejudice. 2. All claims of infringement of the '894 patent ..
More
ORDER GRANTING STIPULATION OF DISMISSAL
JAMES V. SELNA, District Judge.
Upon consideration of the parties' Stipulation of Dismissal, and for good cause having been shown,
IT IS HEREBY ORDERED THAT:
1. All claims of infringement of U.S. Patent No. 5,720,894 ("the '894 patent") that Lawrence Livermore National Security, LLC ("LLNS") has asserted or could have asserted against Abbott Medical Optics Inc. ("AMO") are dismissed with prejudice.
2. All claims of infringement of the '894 patent that Femto-Sec Tech, Inc. ("Femto-Sec") has asserted or could have asserted against AMO are dismissed with prejudice.
3. All counterclaims related to the '894 patent that AMO has asserted or could have asserted against LLNS or Femto-Sec are dismissed with prejudice.
4. LLNS, Femto-Sec, Neev, and AMO will each bear their own costs, expenses and legal fees, except as pursuant to the Mutual Release between LLNS, Femto-Sec, and Neev in which LLNS, Femto-Sec, and Neev reserved all claims against one another related to the '894 patent, including claims for cost and fee sharing for litigating the '894 patent against AMO.
IT IS SO ORDERED.
